NCT07713745 Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2) Status NOT_YET_RECRUITING Phase PHASE2
NCT07708285 Luvometinib in Combination With Serplulimab for NF2-Related Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07652762 IN10018 in Combination With Dalpiciclib for Progressive Meningiomas Status RECRUITING Phase PHASE1
NCT07533942 A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma Status RECRUITING Phase PHASE2
NCT07493447 Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures Status RECRUITING Phase EARLY_PHASE1
NCT07428616 A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma Status RECRUITING Phase PHASE2
NCT07398170 Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study Status RECRUITING Phase NA
NCT06607692 Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). Status RECRUITING Phase PHASE1/PHASE2
NCT06126588 Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial Status RECRUITING Phase PHASE2
NCT06014905 Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma Status RECRUITING Phase PHASE1
NCT05576103 Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients Status RECRUITING Phase N/A
NCT05278208 Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT04638478 PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02693990 A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas Status ACTIVE_NOT_RECRUITING Phase NA